1-40302604-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001852.4(COL9A2):​c.1792+17G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0145 in 1,590,078 control chromosomes in the GnomAD database, including 1,027 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.041 ( 294 hom., cov: 32)
Exomes 𝑓: 0.012 ( 733 hom. )

Consequence

COL9A2
NM_001852.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.438

Publications

4 publications found
Variant links:
Genes affected
COL9A2 (HGNC:2218): (collagen type IX alpha 2 chain) This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. This chain is unusual in that, unlike the other two type IX alpha chains, it contains a covalently attached glycosaminoglycan side chain. Mutations in this gene are associated with multiple epiphyseal dysplasia. [provided by RefSeq, Jul 2008]
COL9A2 Gene-Disease associations (from GenCC):
  • epiphyseal dysplasia, multiple, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Stickler syndrome, type 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • multiple epiphyseal dysplasia due to collagen 9 anomaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive Stickler syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Stickler syndrome
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 1-40302604-C-T is Benign according to our data. Variant chr1-40302604-C-T is described in ClinVar as [Benign]. Clinvar id is 258377.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.118 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL9A2NM_001852.4 linkc.1792+17G>A intron_variant Intron 30 of 31 ENST00000372748.8 NP_001843.1 Q14055

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL9A2ENST00000372748.8 linkc.1792+17G>A intron_variant Intron 30 of 31 1 NM_001852.4 ENSP00000361834.3 Q14055
COL9A2ENST00000482722.5 linkn.2095+17G>A intron_variant Intron 29 of 30 1
COL9A2ENST00000466267.1 linkn.757+17G>A intron_variant Intron 10 of 10 5
COL9A2ENST00000427563.1 linkn.*17G>A downstream_gene_variant 3

Frequencies

GnomAD3 genomes
AF:
0.0409
AC:
6225
AN:
152070
Hom.:
295
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.107
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0437
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.125
Gnomad SAS
AF:
0.0396
Gnomad FIN
AF:
0.0118
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00129
Gnomad OTH
AF:
0.0354
GnomAD2 exomes
AF:
0.0304
AC:
6505
AN:
214164
AF XY:
0.0264
show subpopulations
Gnomad AFR exome
AF:
0.0999
Gnomad AMR exome
AF:
0.0652
Gnomad ASJ exome
AF:
0.00106
Gnomad EAS exome
AF:
0.118
Gnomad FIN exome
AF:
0.0107
Gnomad NFE exome
AF:
0.00176
Gnomad OTH exome
AF:
0.0190
GnomAD4 exome
AF:
0.0117
AC:
16875
AN:
1437894
Hom.:
733
Cov.:
34
AF XY:
0.0118
AC XY:
8398
AN XY:
713898
show subpopulations
African (AFR)
AF:
0.109
AC:
3576
AN:
32696
American (AMR)
AF:
0.0617
AC:
2598
AN:
42136
Ashkenazi Jewish (ASJ)
AF:
0.00121
AC:
31
AN:
25716
East Asian (EAS)
AF:
0.136
AC:
5196
AN:
38090
South Asian (SAS)
AF:
0.0317
AC:
2621
AN:
82594
European-Finnish (FIN)
AF:
0.0120
AC:
594
AN:
49572
Middle Eastern (MID)
AF:
0.00989
AC:
42
AN:
4248
European-Non Finnish (NFE)
AF:
0.000933
AC:
1029
AN:
1103366
Other (OTH)
AF:
0.0200
AC:
1188
AN:
59476
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
907
1814
2720
3627
4534
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
272
544
816
1088
1360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0410
AC:
6236
AN:
152184
Hom.:
294
Cov.:
32
AF XY:
0.0410
AC XY:
3053
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.107
AC:
4433
AN:
41516
American (AMR)
AF:
0.0439
AC:
671
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3468
East Asian (EAS)
AF:
0.126
AC:
647
AN:
5152
South Asian (SAS)
AF:
0.0397
AC:
191
AN:
4814
European-Finnish (FIN)
AF:
0.0118
AC:
125
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00129
AC:
88
AN:
68018
Other (OTH)
AF:
0.0355
AC:
75
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
294
589
883
1178
1472
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0187
Hom.:
38
Bravo
AF:
0.0479
Asia WGS
AF:
0.0700
AC:
243
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Dec 11, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.51
DANN
Benign
0.53
PhyloP100
-0.44
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12038020; hg19: chr1-40768276; API